Kidney diseases, particularly chronic kidney disease (CKD), fundamentally impair the kidneys' ability to eliminate waste ...

In patients with impaired renal function or fast-deteriorating eGFR at baseline, lucerastat was associated with a marked ...

ENYO Pharma ("ENYO"), a clinical-stage biopharmaceutical company developing innovative therapies for kidney diseases, today ...

A new study suggests incremental dialysis may preserve kidney function and improve quality of life without added risk. Read ...

Disagreement between creatinine and cystatin C kidney tests signals a much higher risk of serious disease and death, ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

A fasting-mimicking diet (FMD) restored kidney function in a rodent model and promoted renoprotection in patients with chronic kidney disease (CKD) by reducing proteinuria and improving endothelial ...

Credit: Getty Images Major effects of febuxostat on renal outcome might be uric acid dependent, according to investigators. Beside reducing serum uric acid in patients with chronic kidney disease (CKD ...

Score had temporal stability for patients with stable kidney function, but was responsive for only some with worsening disease.

Scientists have made a remarkable breakthrough in kidney research. In a paper published in the journal Communications Biology, a team of researchers at Kyoto University led by Ramin Sadeghian present ...

Rhabdomyolysis is a condition in which muscle damage—often caused by drug intake—can lead to impaired kidney function and ...

When hydration levels are adequate, kidneys can efficiently dilute urine, flush toxins, and prevent waste accumulation.